Please use this identifier to cite or link to this item: https://doi.org/10.1007/s00280-006-0270-1
Title: Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
Authors: Yeo, W.
Zee, B.
Ma, B.
Lam, K.C.
Mo, F.K.F.
Ng, E.K.W.
Ho, R.
Chan, A.T.C.
Yeo, W.
Boyer, M.
Clarke, S.
Beale, P.
Chung, H.C.
Roh, J.K.
Rha, S.Y.
Jeung, H.C.
Ong, S.Y.K.
Lim, R.
Soo, R.
Goh, B.C. 
Keywords: First line chemotherapy
Irofulven
Stomach cancer
Issue Date: 2007
Source: Yeo, W., Zee, B., Ma, B., Lam, K.C., Mo, F.K.F., Ng, E.K.W., Ho, R., Chan, A.T.C., Yeo, W., Boyer, M., Clarke, S., Beale, P., Chung, H.C., Roh, J.K., Rha, S.Y., Jeung, H.C., Ong, S.Y.K., Lim, R., Soo, R., Goh, B.C. (2007). Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemotherapy and Pharmacology 59 (3) : 295-300. ScholarBank@NUS Repository. https://doi.org/10.1007/s00280-006-0270-1
Source Title: Cancer Chemotherapy and Pharmacology
URI: http://scholarbank.nus.edu.sg/handle/10635/27257
ISSN: 03445704
DOI: 10.1007/s00280-006-0270-1
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Dec 6, 2017

WEB OF SCIENCETM
Citations

13
checked on Nov 21, 2017

Page view(s)

121
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.